Autolus Therapeutics Ltd reported $266.14M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 1.16B Sep/2025
Autolus Therapeutics Ltd USD 266.14M 16.07K Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Novartis USD 1.94B 23.4M Jun/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Silence Therapeutics USD 141.7M 0 Sep/2025